Why Choose the Topolewski Pediatric Heart Valve Center

Part of the internationally recognized Cardiac Center at Children’s Hospital of Philadelphia, the Topolewski Pediatric Heart Valve Center offers comprehensive, expert care and a commitment to ongoing innovation that is redefining possibilities in the field of pediatric valve repair and replacement.


Physicians in cath lab The Topolewski Pediatric Heart Valve Center at CHOP offers patients an unmatched breadth of clinical and scientific expertise. Our surgical team is a world leader in pediatric valve repair and replacement for even the most complex valve disorders. Our interventional cardiologists are pioneers in the area of cardiac catherization. They've published extensively about new procedures, new devices and new options for existing devices, and are often the first to study and use cutting-edge new technologies in both multisite and individual clinical studies. Our echocardiography lab is one of the largest pediatric imaging labs in the country, with over 30,000 echocardiograms performed each year and a staff of 22 physicians specializing in state-of-the-art imaging capabilities that allow our surgical team to customize both surgical and catheter-based interventions.


Hands Hold 3D Heart Our surgical team maintains a seamless integration of care with access to visionary research fueled by the most advanced technology in the world. From 3D heart modeling to the Cardiac Center Virtual Reality Suite for Perioperative Planning, which uses interactive visualization to plan for and simulate surgery, we are breaking ground in unchartered territory and developing customized, patient-specific interventions.


In addition to rapidly developing technology and personalized surgical approaches, research at the Topolewski Pediatric Heart Valve Center is focused on identifying the genetic risk factors associated with valve disease and its progression. Researchers hope these ongoing efforts will lead to the discovery of a first-of-its-kind pharmaceutical treatment with potential for slowing the progression of pediatric valve disease.